Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

Heterogeneity in non-epitope loop sequence and outer membrane protein complexes alters antibody binding to the major porin protein PorB in serogroup B Neisseria meningitidis.

Matthias KA, Strader MB, Nawar HF, Gao YS, Lee J, Patel DS, Im W, Bash MC.

Mol Microbiol. 2017 Jul 14. doi: 10.1111/mmi.13747. [Epub ahead of print]

PMID:
28708335
2.

Human Complement Bactericidal Responses to a Group A Meningococcal Conjugate Vaccine in Africans and Comparison to Responses Measured by 2 Other Group A Immunoassays.

Price GA, Hollander AM, Plikaytis BD, Mocca BT, Carlone G, Findlow H, Borrow R, Sow SO, Diallo A, Idoko OT, Enwere GC, Elie C, Preziosi MP, Kulkarni PS, Bash MC.

Clin Infect Dis. 2015 Nov 15;61 Suppl 5:S554-62. doi: 10.1093/cid/civ504.

PMID:
26553688
3.

Development and use of a serum bactericidal assay using pooled human complement to assess responses to a meningococcal group A conjugate vaccine in African toddlers.

Bash MC, Lynn F, Mocca B, Borrow R, Findlow H, Hassan-King M, Preziosi MP, Idoko O, Sow S, Kulkarni P, Laforce FM.

Clin Vaccine Immunol. 2014 May;21(5):755-61. doi: 10.1128/CVI.00812-13. Epub 2014 Mar 26.

4.

Vaccines against gonorrhea: current status and future challenges.

Jerse AE, Bash MC, Russell MW.

Vaccine. 2014 Mar 20;32(14):1579-87. doi: 10.1016/j.vaccine.2013.08.067. Epub 2013 Sep 6.

5.

Impact of fluoroquinolone resistance mutations on gonococcal fitness and in vivo selection for compensatory mutations.

Kunz AN, Begum AA, Wu H, D'Ambrozio JA, Robinson JM, Shafer WM, Bash MC, Jerse AE.

J Infect Dis. 2012 Jun 15;205(12):1821-9. doi: 10.1093/infdis/jis277. Epub 2012 Apr 5.

6.

Molecular epidemiology of Neisseria meningitidis serogroup B in Brazil.

de Filippis I, de Lemos AP, Hostetler JB, Wollenberg K, Sacchi CT, Dunning Hotopp JC, Harrison LH, Bash MC, Prevots DR.

PLoS One. 2012;7(3):e33016. doi: 10.1371/journal.pone.0033016. Epub 2012 Mar 14. Erratum in: PLoS One. 2012;7(7): doi/10.1371/annotation/6318254d-3f13-4cca-8bbe-08d0ff29aa64. Dunning Hotopp, Julie C [added].

7.

Capsular serotype of Staphylococcus aureus in the era of community-acquired MRSA.

Sutter DE, Summers AM, Keys CE, Taylor KL, Frasch CE, Braun LE, Fattom AI, Bash MC.

FEMS Immunol Med Microbiol. 2011 Oct;63(1):16-24. doi: 10.1111/j.1574-695X.2011.00822.x. Epub 2011 Jul 18.

8.

Utilization of serologic assays to support efficacy of vaccines in nonclinical and clinical trials: meeting at the crossroads.

Madore DV, Meade BD, Rubin F, Deal C, Lynn F; Meeting Contributors.

Vaccine. 2010 Jun 23;28(29):4539-47. doi: 10.1016/j.vaccine.2010.04.094. Epub 2010 May 12.

9.

Investigation of different group A immunoassays following one dose of meningococcal group A conjugate vaccine or A/C polysaccharide vaccine in adults.

Findlow H, Plikaytis BD, Aase A, Bash MC, Chadha H, Elie C, Laher G, Martinez J, Herstad T, Newton E, Viviani S, Papaspyridis C, Kulkarni P, Wilding M, Preziosi MP, Marchetti E, Hassan-King M, La Force FM, Carlone G, Borrow R.

Clin Vaccine Immunol. 2009 Jul;16(7):969-77. doi: 10.1128/CVI.00068-09. Epub 2009 May 27.

10.
11.

Evaluation of PorB variable region typing of Neisseria gonorrhoeae using PCR-ELISA in samples collected from men who have sex with men.

Ling AE, Bash MC, Lynn F, Lister NA, Zhu P, Garland SM, Fairley CK, Tabrizi SN.

J Clin Lab Anal. 2007;21(4):237-43.

PMID:
17621363
12.

Distinguishing importation from diversification of quinolone-resistant Neisseria gonorrhoeae by molecular evolutionary analysis.

PĂ©rez-Losada M, Crandall KA, Bash MC, Dan M, Zenilman J, Viscidi RP.

BMC Evol Biol. 2007 Jun 1;7:84.

13.

Extragenital manifestations of Neisseria gonorrhoeae.

Spencer SE, Bash MC.

Curr Infect Dis Rep. 2006 Mar;8(2):132-8.

PMID:
16524550
14.

por Variable-region typing by DNA probe hybridization is broadly applicable to epidemiologic studies of Neisseria gonorrhoeae.

Bash MC, Zhu P, Gulati S, McKnew D, Rice PA, Lynn F.

J Clin Microbiol. 2005 Apr;43(4):1522-30.

15.

Genetic typing of the porin protein of Neisseria gonorrhoeae from clinical noncultured samples for strain characterization and identification of mixed gonococcal infections.

Lynn F, Hobbs MM, Zenilman JM, Behets FM, Van Damme K, Rasamindrakotroka A, Bash MC.

J Clin Microbiol. 2005 Jan;43(1):368-75.

16.

Quinolone resistance-determining region mutations and por type of Neisseria gonorrhoeae isolates: resistance surveillance and typing by molecular methodologies.

Giles JA, Falconio J, Yuenger JD, Zenilman JM, Dan M, Bash MC.

J Infect Dis. 2004 Jun 1;189(11):2085-93. Epub 2004 Apr 30.

PMID:
15143477
17.

Gonorrhea Update.

Bash MC.

Curr Infect Dis Rep. 2004 Apr;6(2):129-134.

PMID:
15023275
18.

Porin variation among clinical isolates of Neisseria gonorrhoeae over a 10-year period, as determined by Por variable region typing.

McKnew DL, Lynn F, Zenilman JM, Bash MC.

J Infect Dis. 2003 Apr 15;187(8):1213-22. Epub 2003 Apr 2.

PMID:
12696000
19.
20.

Genetic diversity of three lgt loci for biosynthesis of lipooligosaccharide (LOS) in Neisseria species.

Zhu P, Klutch MJ, Bash MC, Tsang RS, Ng LK, Tsai CM.

Microbiology. 2002 Jun;148(Pt 6):1833-44.

PMID:
12055303

Supplemental Content

Loading ...
Support Center